(Q35927834)

11 August 2017

De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer (English)

1 reference

11 August 2017

1 reference

Xiwei Wu

1

1 reference

11 August 2017

George Somlo

2

1 reference

11 August 2017

Yang Yu

3

1 reference

11 August 2017

Melanie R Palomares

4

1 reference

11 August 2017

Arthur Xuejun Li

5

1 reference

11 August 2017

Weiying Zhou

6

1 reference

11 August 2017

Amy Chow

7

1 reference

11 August 2017

Yun Yen

8

1 reference

11 August 2017

John J Rossi

9

1 reference

11 August 2017

Harry Gao

10

1 reference

11 August 2017

Jinhui Wang

11

1 reference

11 August 2017

Yate-Ching Yuan

12

1 reference

11 August 2017

Paul Frankel

13

1 reference

11 August 2017

Sierra Li

14

1 reference

11 August 2017

Kimlin Tam Ashing-Giwa

15

1 reference

11 August 2017

Guihua Sun

16

1 reference

11 August 2017

Yafan Wang

17

1 reference

11 August 2017

Robin Smith

18

1 reference

11 August 2017

Kim Robinson

19

1 reference

11 August 2017

Xiubao Ren

20

1 reference

11 August 2017

Shizhen Emily Wang

21

1 reference

11 August 2017

8 March 2012

1 reference

Journal of Translational Medicine

11 August 2017

1 reference

11 August 2017

10

1 reference

11 August 2017

42

1 reference

https://scigraph.springernature.com/pub.10.1186/1479-5876-10-42

11 August 2017

0 references

cites work

miRNA Biomarkers in Breast Cancer Detection and Management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Selective release of microRNA species from normal and malignant mammary epithelial cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Circulating microRNAs as novel minimally invasive biomarkers for breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Visceral disease in patients with metastatic breast cancer: efficacy and safety of treatment with ixabepilone and other chemotherapeutic agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Breast conservation therapy for patients with locally advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Neoadjuvant chemotherapy for locally advanced breast cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

MicroRNA expression profiling of male breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Detection of cancer with serum miRNAs on an oligonucleotide microarray

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Circulating microRNAs in breast cancer and healthy subjects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Circulating microRNAs as stable blood-based markers for cancer detection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

miR-122, a paradigm for the role of microRNAs in the liver

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

MicroRNA signatures in human cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Metastatic breast cancer: an updating

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Primary systemic therapy for operable breast cancer: a review of clinical trials and perspectives

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

MicroRNA gene expression deregulation in human breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

MicroRNAs: genomics, biogenesis, mechanism, and function

2 October 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

2 October 2017

https://api.crossref.org/works/10.1186%2F1479-5876-10-42

7. Management of advanced breast cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

A truth serum for cancer--microRNAs have major potential as cancer biomarkers.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3342150

Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22400902

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1479-5876-10-42

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

22400902

1 reference